Publisher: John Wiley & Sons Inc
E-ISSN: 2160-7648|7|2|132-142
ISSN: 2160-763X
Source: Clinical Pharmacology In Drug Development, Vol.7, Iss.2, 2018-02, pp. : 132-142
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Clinical Pharmacology In Drug Development, Vol. 4, Iss. 3, 2015-03 ,pp. :
Emtricitabine/Tenofovir Disoproxil Fumarate
Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. :
Emtricitabine/Tenofovir Disoproxil Fumarate
By Toni M. Dando Antona J. Wagstaff
Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. :
By Lu Chengtao Jia Yanyan Yang Jing Song Ying Liu Wenxing Ding Yi Sun Xiaoli Wen Aidong
Clinical Drug Investigation, Vol. 32, Iss. 5, 2012-05 ,pp. :
Emtricitabine/tenofovir DF reduces BMD, shows ASSERT
Reactions Weekly, Vol. 1, Iss. 1324, 2010-01 ,pp. :